Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 May 21;18(19):2300-8.
doi: 10.3748/wjg.v18.i19.2300.

Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Yoshihisa Takahashi  1 , Yurie Soejima, Toshio Fukusato
Affiliations
Review

Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Yoshihisa Takahashi et al. World J Gastroenterol. .

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a condition in which excess fat accumulates in the liver of a patient without a history of alcohol abuse. Nonalcoholic steatohepatitis (NASH), a severe form of NAFLD, can progress to liver cirrhosis and hepatocellular carcinoma. NAFLD is regarded as a hepatic manifestation of metabolic syndrome and incidence has been increasing worldwide in line with the increased prevalence of obesity, type 2 diabetes, and hyperlipemia. Animal models of NAFLD/NASH give crucial information, not only in elucidating pathogenesis of NAFLD/NASH but also in examining therapeutic effects of various agents. An ideal model of NAFLD/NASH should correctly reflect both hepatic histopathology and pathophysiology of human NAFLD/NASH. Animal models of NAFLD/NASH are divided into genetic, dietary, and combination models. In this paper, we review commonly used animal models of NAFLD/NASH referring to their advantages and disadvantages.

Keywords: Animal model; Histopathology; Metabolic syndrome; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Liver histology of rats fed a high-fructose diet for 5 wk. A: Hepatic steatosis, mainly distributed in zone 1, is observed (azan stain, × 40); B: Both macrovesicular and microvesicular steatosis are evident as well as scattered necroinflammatory foci (arrows) (hematoxylin and eosin stain, × 200).
Figure 2
Figure 2
Liver histology of rats fed a high-fructose diet + plant leaf extract. Hepatic fatty change is completely suppressed by the plant leaf extract (hematoxylin and eosin stain, × 40).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221–1231. - PubMed
    1. Takahashi Y, Fukusato T. Pathology of nonalcoholic steatohepatitis. In: Current Research in Hepatology 2., editor. Trivandrum: Research Media; 2008. pp. 99–112.
    1. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 1990;11:74–80. - PubMed
    1. Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol. 2003;98:2042–2047. - PubMed
    1. Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science. 2011;332:1519–1523. - PMC - PubMed